Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sihan Tan

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Thoracic Disease|March 14, 2025
Development a predictive nomogram for spontaneous pleurodesis in patients with non-small cell lung cancer and malignant pleural effusionSihan Tan, Hao Zeng, Qin Huang, et al.
Medcomm|June 6, 2024
The combination of tumor mutational burden and T-cell receptor repertoire predicts the response to immunotherapy in patients with advanced non-small cell lung cancerYalun Li, Liyan Ji, Yingqian Zhang, et al.
BMC Cancer|March 29, 2024
Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter studyQi Wei, Taibing Deng, Junhua Wu, et al.
Journal of Thoracic Disease|September 15, 2025
Association of peripheral-blood neutrophil-to-lymphocyte ratio with <i>Pneumocystis jirovecii</i> pneumonia in patients with solid tumors: a case-control studyHao Zeng, Yue Gou, Chang Qi, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Thoracic Disease|March 14, 2025
Development a predictive nomogram for spontaneous pleurodesis in patients with non-small cell lung cancer and malignant pleural effusionSihan Tan, Hao Zeng, Qin Huang, et al.
Medcomm|June 6, 2024
The combination of tumor mutational burden and T-cell receptor repertoire predicts the response to immunotherapy in patients with advanced non-small cell lung cancerYalun Li, Liyan Ji, Yingqian Zhang, et al.
BMC Cancer|March 29, 2024
Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter studyQi Wei, Taibing Deng, Junhua Wu, et al.
Journal of Thoracic Disease|September 15, 2025
Association of peripheral-blood neutrophil-to-lymphocyte ratio with <i>Pneumocystis jirovecii</i> pneumonia in patients with solid tumors: a case-control studyHao Zeng, Yue Gou, Chang Qi, et al.
Pageof 2